Evidence map›Paper›PMID 41620614›Full record

ArticleBMC medical imaging2026

Cellularity habitat-based MRI radiomics for non-invasive grading and IDH mutation prediction in adult-type diffuse glioma.

Fangrong Liang, Xin Zhen, Jiaxin Lin, Junjie Li, Jie Zhan, Ruili Wei, Wanli Zhang, Yujie He, Mengni Wu, Yongzhou Xu and 3 more

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fangrong LiangDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Xin ZhenSchool of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Jiaxin LinDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Junjie LiDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, No. 119, South Fourth Ring West Road, Fengtai District, Beijing, 100070, China.
Jie ZhanDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Ruili WeiDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Wanli ZhangDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Yujie HeDepartment of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China.
Mengni WuThe First School of Clinical Medicine, Guangdong Medical College, Zhanjiang, Guangdong, 524023, China.
Yongzhou XuPhilips Healthcare, Guangzhou, Guangdong, 510180, China.
Yaou Liu *Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, No. 119, South Fourth Ring West Road, Fengtai District, Beijing, 100070, China. liuyaou@bjtth.org.
Shengsheng Lai *School of Medical Equipment, Guangdong Food and Drug Vocational College, Guangzhou, Guangdong, 510520, China. laiss@gdyzy.edu.cn.
Ruimeng Yang *Department of Radiology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), No. 1, Panfu Road, Yuexiu District, Guangzhou, Guangdong, 510180, China. eyruimengyang@scut.edu.cn.

Funding

Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine 202201020376Medical Science and Technology Research Project of Guangdong Province A2024637the Guangdong Basic and Applied Basic Research Foundation 2021A1515220060the Guangdong Natural Science Foundation 2024A1515012177the National Natural Science Foundation of China 82371908, 81971574
6 · The paper itself

Abstract

backgroundMagnetic resonance imaging (MRI) radiomics has shown promise in glioma grading and isocitrate dehydrogenase (IDH) mutation prediction, but traditional whole-tumor approaches overlook intratumoral heterogeneity, limiting diagnostic accuracy and interpretability. This study aims to explore cellularity habitat-based MRI radiomics for precise grading and IDH mutation status prediction in adult-type diffuse glioma (ADG).

methodsA total of 625 ADG patients were retrospectively collected. Whole-tumor volumes of interest (VOIs) were delineated on four conventional MRI sequences (T1WI, T2WI, T2-FLAIR, and CE-T1WI) and segmented into three cellularity habitats using apparent diffusion coefficient (ADC)-based K-means clustering: H

resultsThe optimal habitats for ADG grading (Grade 2 vs. Grade 3 + 4, Grade 2 + 3 vs. Grade 4) and IDH prediction were H

conclusionsIntegrating ADC-derived cellularity habitats with MRI radiomics significantly improves the accuracy and biological interpretability of ADG grading and IDH mutation status prediction, offering a robust, non-invasive approach for glioma characterization.

trial registrationRetrospectively registered.

Indexed as

Brain NeoplasmsGliomaIsocitrate DehydrogenaseMagnetic Resonance ImagingAdultAgedFemaleHumansMaleMiddle AgedMutationNeoplasm GradingRadiomicsRetrospective StudiesSensitivity and SpecificityIsocitrate DehydrogenaseGliomaHabitatMagnetic resonance imagingRadiomics

Identifiers

PMID41620614
PMCPMC12947392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.